By Mill Chart
Last update: Mar 13, 2024
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted SHOCKWAVE MEDICAL INC showing up in our growth with base formation screen, so it may be worth spending some more time on it.
A key component of ChartMill's stock assessment is the Growth Rating, which spans from 0 to 10. This rating evaluates diverse growth factors, such as EPS and revenue growth, considering both past performance and future projections. NASDAQ:SWAV has received a 8 out of 10:
ChartMill assigns a proprietary Health Rating to each stock. The score is computed by evaluating various liquidity and solvency ratios and ranges from 0 to 10. NASDAQ:SWAV was assigned a score of 6 for health:
Discover ChartMill's exclusive Profitability Rating, a proprietary metric that assesses stocks on a scale of 0 to 10. It takes into consideration various profitability ratios and margins, both in absolute terms and relative to industry peers. Notably, NASDAQ:SWAV has achieved a 6:
Besides the Technical Rating, ChartMill also assign a Setup Rating to every stock. This setup score also ranges from 0 to 10 and determines to which extend the stock is consolidating. This is achieved by evaluating multiple short term technical indicators. NASDAQ:SWAV currently has a 8 as setup rating:
SWAV has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is very little resistance above the current price. There is a support zone below the current price at 258.42, a Stop Loss order could be placed below this zone. Another positive sign is the recent Pocket Pivot signal.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
Our latest full fundamental report of SWAV contains the most current fundamental analsysis.
Our latest full technical report of SWAV contains the most current technical analsysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
SHOCKWAVE MEDICAL INC
NASDAQ:SWAV (4/18/2024, 7:22:16 PM)
After market: 327.52 0 (0%)327.52
+0.02 (+0.01%)
Investors wondering which tax refund stocks to invest in should consider these names, each of which is a capital compounder.
Is SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) on the Verge of a Major Breakout as a Strong Growth Stock?
In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.
These stocks to buy have enjoyed big rallies and the gains look likely to continue in coming months even if the market does peak.
These three dividend kings are among the most reliable dividend stocks, and each has at least one strong buy rating.
The company is hoping to expand, but is there enough here to attract growth investors?
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Income-seeking investors can look forward to steady payout raises from these pharma stocks.
Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory Angina